Palantir co-founder Peter Thiel has argued for more than two years that death is a problem humans can overcome, investing money into aging research. Add to this Altos Labs backed by Jeff Bezos, Google's Calico, NewLimit founded by Coinbase co-founders, and Retro Biosciences backed by Sam Altman... Silicon Valley heavyweights are diving into aging and life extension research. The scale of related investments is also growing rapidly.

The research does not just stay at the stage of simple ideas. "Partial reprogramming" research to revert cells to a youthful state has moved past animal testing to the initial clinical trial stage targeting humans, and research using AI to find more effective combinations or improve existing factors is also underway. If the technology advances, will our humanity be able to conquer death as Peter Thiel thinks? In today's O-Graph, we examined through five graphs how far the dream of "eternal life" has become science and where it starts to become a massive business.

(Reported by An Hyemin | Filmed by Hwang Se-hoe and Cha Seung-hwan | Edited by Lee Ki-eun | Designed by Ahn Jun-seok | Intern Shin Yeon-seong | Produced by Knowledge Content IP Team)